Potential of Curcumin in the Management of Skin Diseases

Kamila Kasprzak-Drozd,Przemysław Niziński,Anna Hawrył,Marek Gancarz,Dominika Hawrył,Weronika Oliwa,Magdalena Pałka,Julia Markowska,Anna Oniszczuk
DOI: https://doi.org/10.3390/ijms25073617
IF: 5.6
2024-03-24
International Journal of Molecular Sciences
Abstract:Curcumin is a polyphenolic molecule derived from the rhizoma of Curcuma longa L. This compound has been used for centuries due to its anti-inflammatory, antioxidant, and antimicrobial properties. These make it ideal for preventing and treating skin inflammation, premature skin ageing, psoriasis, and acne. Additionally, it exhibits antiviral, antimutagenic, and antifungal effects. Curcumin provides protection against skin damage caused by prolonged exposure to UVB radiation. It reduces wound healing times and improves collagen deposition. Moreover, it increases fibroblast and vascular density in wounds. This review summarizes the available information on the therapeutic effect of curcumin in treating skin diseases. The results suggest that curcumin may be an inexpensive, well-tolerated, and effective agent for treating skin diseases. However, larger clinical trials are needed to confirm these observations due to limitations in its in vivo use, such as low bioavailability after oral administration and metabolism.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper attempts to address the potential of curcumin in the treatment of skin diseases and its specific application effects. The authors review the mechanisms of action of curcumin in dealing with various skin diseases (such as psoriasis, scleroderma, etc.) and explore the potential benefits of its anti-inflammatory, antioxidant, and immunomodulatory properties on skin health. Additionally, the paper discusses the issue of curcumin's low bioavailability and how this can be improved through novel drug delivery systems, aiming to find a cost-effective, well-tolerated, and effective treatment method for skin diseases. However, due to the limitations of curcumin's use in vivo, such as low bioavailability and metabolic issues after oral administration, larger-scale clinical trials are still needed to verify the effectiveness of these observations.